Breaking News Instant updates and real-time market news.

MRK

Merck

$75.83

-1.67 (-2.15%)

, BMY

Bristol-Myers

$45.63

-0.4 (-0.87%)

10:25
04/17/19
04/17
10:25
04/17/19
10:25

Cantor Fitzgerald healthcare analysts to hold analyst/industry conference call

Analysts, along with a Chinese oncologist and Chinese VP of Regulatory Affairs discuss the Chinese PD-1 opportunity relating to Merck's Keytruda and Bristol-Myers Squibb's Opdivo on an Analyst/Industry conference call to be held on April 17 at 11 am.

MRK

Merck

$75.83

-1.67 (-2.15%)

BMY

Bristol-Myers

$45.63

-0.4 (-0.87%)

  • 17

    Apr

  • 25

    Apr

  • 30

    Apr

  • 06

    May

  • 18

    May

  • 20

    May

  • 03

    Jun

  • 17

    Jun

  • 20

    Jun

  • 16

    Jul

  • 06

    Aug

  • 20

    Sep

MRK Merck
$75.83

-1.67 (-2.15%)

03/20/19
SBSH
03/20/19
NO CHANGE
SBSH
Bayer shares likely to remain 'depressed' pending trial success, says Citi
While sentiment will "clearly take a knock" at the second Roundup trial going against Bayer (BAYRY), both verdicts were delivered by juries in California and EUR 22B of litigation risk is already priced into the shares, Citi analyst Peter Verdult tells investors in a research note. The analyst says his legal checks continue to instruct him to be more focused on the upcoming Hall vs. Monsanto trial being held in St Louis from April 1. He says that verdict will better determine whether his estimate of a potential settlement liability of $1B-$6B needs to be refined. However, Bayer shares will "likely remain depressed" until there is evidence of the company prevailing in one or more of the six cases to go to trial in 2019, Verdult contends. He keeps a Buy rating on the stock but prefers other Pharma plays AstraZeneca (AZN), Sanofi (SNY), Novartis (NVS) and Merck (MRK).
03/13/19
CANT
03/13/19
NO CHANGE
Target $95
CANT
Overweight
Merck opportunity in China is underappreciated, says Cantor Fitzgerald
After taking a deeper look at the Chinese PD-1 market, Cantor Fitzgerald analyst Louise Chen believes it could equate to billions of sales that are not yet in the forecasts for Merck's Keytruda. She thinks the peak sales potential of PD-1s in China remains underappreciated. China's pharma market can grow to $225B by 2025, which would support a growing PD-1/PD-L1 market, Chen tells investors in a research note titled "Deep Dive into China: A Complicated but Underappreciated Opportunity." The analyst keeps an Overweight rating on Merck with a $95 price target.
03/11/19
WBLR
03/11/19
NO CHANGE
WBLR
Outperform
William Blair sum-of-the-parts analysis yields $19.80 value for Pfenex
The majority of Pfenex (PFNX) investor focus has been placed on lead asset PF708, the therapeutic equivalent product candidate to Forteo, William Blair analyst Andy Hsieh tells investors in a research note, citing his talks with clients. The analyst, however, sees "potential for significant value" from the company's collaboration with Jazz Pharmaceuticals (JAZZ). The deal with Jazz could provide patients with an alternative to Erwinaze/Erwinase, which currently suffers from significant supply constraints, and CRM197, a carrier protein that is incorporated as an adjuvant in several vaccine candidates, including Merck's (MRK) pneumococcal vaccine, V114, Hsieh writes. Based on these royalties, the analyst conducted a sum-of-the-parts analysis for Pfenex based on discounted cash flow, and the resulting net present value yielded a value of $19.80 per share. The stock closed Monday at $4.26. The analyst believes the company's "value-creating" catalysts this year, including milestone payment from Jazz for the successful tech transfer of PF743 and PF745 and the approval of PF708, coupled with his valuation analysis, affirm his bullish thesis. Hsieh believes Pfenex shares offer one of the best risk/reward symmetries in small-cap biotech and reiterates an Outperform rating on the name.
02/22/19
CANT
02/22/19
INITIATION
Target $95
CANT
Overweight
Merck initiated with an Overweight at Cantor Fitzgerald
Cantor Fitzgerald analyst Louise Chen started Merck with an Overweight rating and $95 price target. The company's sales growth across oncology, vaccines, animal health, and select hospital/specialty care products, as well as its margin expansion opportunities, are underappreciated at current share levels, Chen tells investors in a research note. She expects upward earnings revisions and multiple expansion in 2019 to drive Merck shares higher.
BMY Bristol-Myers
$45.63

-0.4 (-0.87%)

04/05/19
CANT
04/05/19
DOWNGRADE
Target $100
CANT
Neutral
Cantor sees Bristol deal closing, downgrades Celgene to Neutral
Cantor Fitzgerald analyst Alethia Young downgraded Celgene (CELG) to Neutral from Overweight with an unchanged price target of $100. The analyst expects the takeover by Bristol-Myers (BMY) to close.
04/02/19
BERN
04/02/19
DOWNGRADE
BERN
Market Perform
Celgene downgraded to Market Perform from Outperform at Bernstein
Bernstein analyst Aaron Gal downgraded Celgene (CELG) to Market Perform from Outperform as spread narrows. The analyst notes that the current controversy on Celgene is whether the Bristol-Myers (BMY) acquisition will close. With limited upside, no differentiated views on the main controversy, and ahead of the shareholder vote on April 12th, the analyst is moving to the sidelines.
04/01/19
UBSW
04/01/19
DOWNGRADE
Target $102
UBSW
Neutral
Celgene downgraded to Neutral from Buy at UBS
UBS analyst Carter Gould downgraded Celgene (CELG) to Neutral from Buy while raising his price target for the shares to $102 from $94. After ISS and Glass Lewis on Friday recommended that Bristol-Myers Squibb (BMY) shareholders vote in favor of the proposed acquisition, and Starboard dropped its proxy solicitation in opposition, the analyst sees an increasingly high probability that Bristol's acquisition of Celgene will be completed. He sees any lingering risks around antitrust concerns and Revlimid litigation as unlikely to derail the deal.
04/01/19
WBLR
04/01/19
DOWNGRADE
WBLR
Market Perform
Celgene downgraded to Market Perform from Outperform at William Blair
William Blair analyst Andy Hsieh downgraded Celgene (CELG) to Market Perform from Outperform saying the recent proxy recommendations set the course for the takeover by Bristol-Myers Squibb (BMY) winning shareholder approval.

TODAY'S FREE FLY STORIES

TSLA

Tesla

$258.70

-5.15 (-1.95%)

, MXWL

Maxwell

$4.28

-0.095 (-2.17%)

18:31
04/24/19
04/24
18:31
04/24/19
18:31
Hot Stocks
Tesla says 50% of deliveries occurred in last 10 days of quarter »

Says: Overseas volume…

TSLA

Tesla

$258.70

-5.15 (-1.95%)

MXWL

Maxwell

$4.28

-0.095 (-2.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

OMAB

OMA Airports

$48.34

-0.25 (-0.51%)

18:18
04/24/19
04/24
18:18
04/24/19
18:18
Earnings
OMA Airports reports Q1 EPS 67c, two estimates 73c »

Reports Q1 traffic up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

HMC

Honda

$27.70

-0.8 (-2.81%)

18:07
04/24/19
04/24
18:07
04/24/19
18:07
Hot Stocks
Honda to recall roughly 94,000 cars in U.S. over faulty timing belts »

Honda said it will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

NTDOY

Nintendo

$0.00

(0.00%)

18:05
04/24/19
04/24
18:05
04/24/19
18:05
Hot Stocks
Nintendo says 'Super Mario Maker 2' coming to Switch June 28 »

Nintendo announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Jun

ARGO

Argo Group

$74.46

0.515 (0.70%)

18:04
04/24/19
04/24
18:04
04/24/19
18:04
Hot Stocks
Argo Group says Voce making 'false and misleading' statements about company »

Argo Group International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Jun

SJW

SJW Corp.

$61.56

0.3 (0.49%)

18:03
04/24/19
04/24
18:03
04/24/19
18:03
Earnings
SJW Corp. reports Q1 EPS 21c with items, consensus 14c »

Reports Q1 revenue 77.7M$…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 25

    Apr

CE

Celanese

$110.96

-1.19 (-1.06%)

18:02
04/24/19
04/24
18:02
04/24/19
18:02
Hot Stocks
Celanese announces acetyl intermediates price increases »

Celanese Corporation will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

ISTR

Investar Holding

$22.45

-0.09 (-0.40%)

18:02
04/24/19
04/24
18:02
04/24/19
18:02
Earnings
Investar Holding reports Q1 EPS 46c, consensus 45c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

MSFT

Microsoft

$125.00

-0.5 (-0.40%)

18:00
04/24/19
04/24
18:00
04/24/19
18:00
Earnings
Microsoft sees total Q4 revenue at implied $32.2B-$32.9B, consensus $32.63B »

By segment, sees Q4…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 28

    Apr

  • 03

    Jun

  • 03

    Jun

  • 08

    Jun

  • 10

    Jun

  • 23

    Jun

  • 06

    Aug

ISBC

Investors Bancorp

$12.27

0.07 (0.57%)

17:52
04/24/19
04/24
17:52
04/24/19
17:52
Earnings
Investors Bancorp reports Q1 EPS 18c, consensus 20c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 08

    May

  • 13

    May

  • 21

    May

FB

Facebook

$182.64

-1.13 (-0.61%)

17:51
04/24/19
04/24
17:51
04/24/19
17:51
Hot Stocks
Facebook CEO says 'quite focused on' commerce and payments »

Says "quite focused…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 28

    Apr

  • 30

    May

  • 03

    Jun

FB

Facebook

$182.64

-1.13 (-0.61%)

17:42
04/24/19
04/24
17:42
04/24/19
17:42
Hot Stocks
Facebook says encrypted communications to be big focus in next couple of years »

Says shift to encrypted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 28

    Apr

  • 30

    May

  • 03

    Jun

CLB

Core Laboratories

$72.91

-1.605 (-2.15%)

17:42
04/24/19
04/24
17:42
04/24/19
17:42
Earnings
Core Laboratories sees Q2 EPS 47c-50c, consensus 49c »

Sees Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 30

    Apr

  • 01

    May

CLB

Core Laboratories

$72.91

-1.605 (-2.15%)

17:41
04/24/19
04/24
17:41
04/24/19
17:41
Earnings
Core Laboratories reports Q1 adjusted EPS 44c, consensus 43c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 30

    Apr

  • 01

    May

MSFT

Microsoft

$125.00

-0.5 (-0.40%)

17:41
04/24/19
04/24
17:41
04/24/19
17:41
Hot Stocks
Microsoft CEO says LinkedIn saw 'record level of engagement' in Q3 »

Says LinkedIn marketing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 28

    Apr

  • 03

    Jun

  • 03

    Jun

  • 08

    Jun

  • 10

    Jun

  • 23

    Jun

  • 06

    Aug

TSLA

Tesla

$258.70

-5.15 (-1.95%)

17:40
04/24/19
04/24
17:40
04/24/19
17:40
Hot Stocks
Tesla CEO Musk says large number of vehicle deliveries shifted into Q2 »

Says: Expects 1M robo…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

FB

Facebook

$182.64

-1.13 (-0.61%)

17:33
04/24/19
04/24
17:33
04/24/19
17:33
Hot Stocks
Facebook sees changes making mobile ad targeting more difficult »

Says year-over-year…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 28

    Apr

  • 30

    May

  • 03

    Jun

PKG

Packaging Corp.

$98.86

0.33 (0.33%)

17:32
04/24/19
04/24
17:32
04/24/19
17:32
Earnings
Breaking Earnings news story on Packaging Corp. »

Packaging Corp sees Q2…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 07

    May

  • 13

    Nov

PKG

Packaging Corp.

$98.86

0.33 (0.33%)

17:30
04/24/19
04/24
17:30
04/24/19
17:30
Hot Stocks
Breaking Hot Stocks news story on Packaging Corp. »

Packaging Corp reports Q1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 07

    May

  • 13

    Nov

TSLA

Tesla

$258.70

-5.15 (-1.95%)

17:30
04/24/19
04/24
17:30
04/24/19
17:30
Earnings
Tesla expects to significantly reduce loss in Q2, return to profitability in Q3 »

Tesla CEO Elon Musk said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

FOLD

Amicus

$13.15

-0.12 (-0.90%)

17:30
04/24/19
04/24
17:30
04/24/19
17:30
Syndicate
Breaking Syndicate news story on Amicus »

Amicus files automatic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$182.64

-1.13 (-0.61%)

17:29
04/24/19
04/24
17:29
04/24/19
17:29
Hot Stocks
Facebook says number of ad impressions served across all services rose 32% in Q1 »

Comments taken from Q1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 28

    Apr

  • 30

    May

  • 03

    Jun

PKG

Packaging Corp.

$98.86

0.33 (0.33%)

17:29
04/24/19
04/24
17:29
04/24/19
17:29
Earnings
Packaging Corp. reports Q1 adjusted EPS $1.98, consensus $1.96 »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 07

    May

  • 13

    Nov

TSLA

Tesla

$258.70

-5.15 (-1.95%)

17:29
04/24/19
04/24
17:29
04/24/19
17:29
Earnings
Tesla sees 2019 capital expenditures of $2.0B-$2.5B »

Tesla CEO Elon Musk said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

MEOH

Methanex

$57.37

-1.63 (-2.76%)

17:28
04/24/19
04/24
17:28
04/24/19
17:28
Earnings
Methanex reports Q1 adjusted EPS 73c, consensus 88c »

Reports Q1 revenue $733M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.